Project Grant R01EY038008
Award Date 9/1/25
Completion Date 8/31/28
Dollars Obligated $1.6M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Illinois, USA
Similar Awards
- This $439,016 federal Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) aims to provide initial proof-of-concept for a novel therapeutic approach to glaucoma. The goal is to target the progressive TGFβ2-associated aqueous outflow pathway pathology in a feline model of early onset glaucoma. The project involves optimizing viral vector-mediated transduction of feline trabecular meshwork cells to suppress pathologic TGFβ2 signaling, which contributes to increased...
- This federal Project Grant award of $764,881 from the National Eye Institute (CFDA 93.867 - Vision Research) supports research to investigate the role of advanced glycation end products (AGEs) in primary open-angle glaucoma (POAG). The overarching hypothesis is that the accumulation of AGEs in the trabecular meshwork promotes extracellular matrix remodeling and cell dysfunction, leading to increased outflow resistance and elevated intraocular pressure in POAG. The research project has two...
- This $417,162 Project Grant award from the National Eye Institute (CFDA 93.867 - Vision Research) supports research on using optical techniques to detect early signs of glaucoma, the leading cause of irreversible blindness worldwide. The University of Houston System, the grantee, will conduct research to determine if changes in the birefringence (optical properties) of the lamina cribrosa and posterior eye structures can serve as sensitive early indicators of glaucoma before structural damage...
- This Project Grant award of $568,122.00, provided by the National Eye Institute (CFDA 93.867 - Vision Research), supports research at Baylor College of Medicine to unequivocally confirm the contribution of the neurovascular unit to glaucoma pathogenesis and identify endothelial cell-specific ligands with potential for neuroprotective therapy. The research aims to globally map ligands binding to ocular hypertension and healthy retinal cells, systematically identifying ocular...
- This $735,937 Project Grant, awarded by the National Eye Institute (CFDA 93.867 - Vision Research), aims to test the effectiveness of a technology-based approach to screening for glaucoma and other eye diseases at Federally Qualified Health Centers (FQHCs). The University of Michigan, as the primary awardee, will utilize digital ophthalmic data captured by FQHC technicians to help eye doctors at the FQHCs triage patients to appropriate care, including 30-minute detailed visits or 10-minute...
- The University of Missouri System received a Project Grant award from the National Eye Institute (NEI) under the Vision Research program (CFDA 93.867). The $412,811 award, effective September 1, 2023 through August 31, 2025, supports the development of a novel adjustable glaucoma drainage device (AGDD) to regulate intraocular pressure. The project aims to design and fabricate a magnetically-responsive shape memory polymer composite valve integrated into a conventional shunt tube. This AGDD would...
- This Project Grant award from the National Science Foundation (NSF) Engineering program (CFDA 47.041) provides $589,056 to the Regents of the University of Michigan, doing business as the University of Michigan-Dearborn, to study the biomechanics of aqueous fluid flow in the eyes' veins. The project aims to determine velocity profiles in the aqueous veins, measure strains in vein walls and adjacent sclera, and investigate correlations between vein flow, outflow facility, vein dilation, and...
- This federal Project Grant awarded by the National Science Foundation (NSF) Engineering program (CFDA 47.041) aims to create innovative tools to understand neurodegeneration in glaucoma blindness. The $600,000 award, with a project period from Jul 1, 2025 to Jun 30, 2030, supports the development of an integrated platform that combines bioengineering tools and neurobiological studies. Key components include: (1) an injectable microbead-based in vivo flow occlusion model to replicate...
- The National Eye Institute (NEI) awarded a $451,000 Project Grant under the Vision Research federal grant program (CFDA 93.867) to The Regents of the University of California, San Francisco (UCSF) to conduct a multimodal characterization of a novel inherited mouse model of glaucoma. The research aims to evaluate structural and functional changes in the mouse model, including axonal degeneration, retinal ganglion cell loss, dendritic changes, and neuroinflammatory responses. It will also identify...
- The Project Grant award from the National Eye Institute (CFDA 93.867 Vision Research) supports the development of an accurate, non-invasive, and automated 24-hour intraocular pressure (IOP) monitoring device. The overarching goal is to create a wearable IOP monitor that can improve the clinical management of glaucoma, the leading cause of irreversible blindness. The $713,964 award will fund research activities over a 5-year period from March 2025 to February 2030 at the University of California,...